Supplementary Table 1 from Multiplexed P21/MCM-2 Detection Predicts Relapse and May Identify Tyrosine Kinase Inhibitor–Resistant Patients in Clear Cell Renal Cell Carcinoma

作者：Hazem Abdullah, In Hwa Um, Grant D. Stewart, Chang Wook Jeong, Cheol Kwak, Kyung Chul Moon, Alexander Laird, Eleni Frangou, Tim Eisen, Angela Meade, David J. Harrison · 年份：2026 · DOI：10.1158/2767-9764.32702061 · 研究领域：Renal cell carcinoma treatment、Multiple and Secondary Primary Cancers、Renal and related cancers

Comparison of prognostic model discrimination with and without the P21+/MCM2− biomarker